Osimertinib in Resected EGFR-Mutated NSCLC. Di Maio M. N Engl J Med 2023;389:1341-1342.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Di Maio M. Osimertinib in Resected EGFR-Mutated NSCLC. N Engl J Med 2023;389:1341-1342.
PMID: 37792622